Compounds > rufloxacin
Page last updated: 2024-08-24

rufloxacin and Respiratory Tract Infections

rufloxacin has been researched along with Respiratory Tract Infections in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrews, J; Greaves, I; Honeybourne, D; Imbimbo, BP; Wise, R1
Acar, JF; Bauernfeind, A; Duval, J; Finch, RG; Focht, J; Nicoletti, G; Phillips, I; Pratts, G; Schito, GC; Soriano, F; Wiedeman, B; Wise, R1
Cogo, R; Imbimbo, BP; Mattina, R; Rimoldi, R1
Colombrita, D; Foresti, I; Peroni, L; Pinsi, G; Pirali, F; Ravizzola, G; Turano, A1

Other Studies

4 other study(ies) available for rufloxacin and Respiratory Tract Infections

ArticleYear
The penetration of rufloxacin into sites of potential infection in the respiratory tract.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:6

    Topics: Anti-Infective Agents; Bronchi; Bronchoalveolar Lavage Fluid; Epithelium; Female; Fluoroquinolones; Humans; Lung; Macrophages, Alveolar; Male; Middle Aged; Mucous Membrane; Quinolones; Respiratory Tract Infections

1993
A multinational European survey on the in-vitro activity of rufloxacin and other comparative antibiotics on respiratory and urinary bacterial pathogens.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:4

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; France; Germany; Italy; Microbial Sensitivity Tests; Quinolones; Respiratory Tract Infections; Spain; United Kingdom; Urinary Tract Infections

1996
Steady-state pharmacokinetics of rufloxacin in elderly patients with lower respiratory tract infections.
    Therapeutic drug monitoring, 1992, Volume: 14, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Half-Life; Humans; Male; Middle Aged; Models, Biological; Quinolones; Respiratory Tract Infections; Spectrophotometry, Ultraviolet

1992
Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Drugs under experimental and clinical research, 1989, Volume: 15, Issue:1

    Topics: 4-Quinolones; Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Female; Fluoroquinolones; Male; Mice; Microbial Sensitivity Tests; Quinolones; Respiratory Tract Infections; Skin Diseases, Infectious

1989